Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3075-3083

  Neumann, Jürgen ^a   Eis Hübinger, Anna Maria ^b   Koch, Norbert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN B; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1I; HLA DM ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE ACTIVATION; CARBOHYDRATE METABOLISM; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HELPER CELL; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS PATHOGENESIS;

EID: 0041331704     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3075     Document Type: Article

References (53)

1. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173.
2. Hill, A. B., B. C. Barnett, A. J. McMichael, and D. J. McGeoch. 1994. HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J. Immunol. 152:2736
3. Früh, K., K. Ahn, H. Djaballah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415.
4. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
5. Deshpande, S. P., U. Kumaraguru, and B. T. Rouse. 2000. Dual role of B cells in mediating innate and acquired immunity to herpes simplex virus infections. Cell. Immunol. 202:79.
6. + cells. J. Virol. 65:6008.
7. Roche, P. A., and P. Cresswell. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA 88:3150.
8. Castellino, F., and R. N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73.
9. Mosyak, L., D. M. Zaller, and D. C. Wiley. 1998. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377.
10. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
11. Sanderson, F., M. J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J. J. Neefjes, H. J. Geuze, and J. Trowsdale. 1994. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566.
12. Belmares, M. P., R. Busch, K. W. Wucherpfennig, H. M. McConnell, and E. D. Mellins. 2002. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J. Immunol. 169:5109.
13. + T cells. J. Immunol. 166:6242.
14. Sievers, E., J. Neumann, M. Raftery, G. Schönrich, A. M. Eis-Hübinger, and N. Koch. 2002. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules. Immunology 107:129.
15. Wraight, C. J., P. van Endert, P. Möller, J. Lipp, N. R. Ling, I. C. MacLennan, N. Koch, and G. Moldenhauer. 1990. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J. Biol. Chem. 265:5787.
16. Watanabe, M., T. Suzuki, M. Taniguchi, and N. Shinohara. 1983. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans. Transplantation 36:712.
17. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293.
18. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9.
19. Eis-Hübinger, A. M., D. S. Schmidt, and K. E. Schneweis. 1993. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:379.
20. Adams, T. E., J. G. Bodmer, and W. F. Bodmer. 1983. Production and characterization of monoclonal antibodies recognizing the α-chain subunits of human Ia alloantigens. Immunology 50:613.
21. Stam, N. J., T. M. Vroom, P. J. Peters, E. B. Pastoors, and H. L. Ploegh. 1990. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in Formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol. 2:113.
22. Sanderson, F., C. Thomas, J. Neefjes, and J. Trowsdale. 1996. Association between HLA-DM and HLA-DR in vivo. Immunity 4:87.
23. Radsak, K., K. H. Brucher, W. Britt, H. Shiou, D. Schneider, and A. Kollert. 1990. Nuclear compartmentation of glycoprotein B of human cytomegalovirus. Virology 177:515.
24. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
25. Neumann, J., N. Schach, and N. Koch. 2001. Glycosylation signals that separate the trimerization from the MHC class II-binding domain control intracellular degradation of invariant chain. J. Biol. Chem. 276:13469.
26. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
27. L41 genes of herpes simplex virus 1. J. Virol. 76:6974.
28. + T lymphocytes. Cell 77:525.
29. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo, O. Schwartz, and P. Benaroch. 2001. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98:12144.
30. Slobedman, B., E. S. Mocarski, A. M. Arvin, E. D. Mellins, and A. Abendroth. 2002. Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood 100:2867.
31. + T cells. Nat. Med. 5:I039.
32. Hegde, N. R., R. A. Tomazin, T. W. Wisner, C. Dunn, J. M. Boname, D. M. Lewinsohn, and D. C. Johnson. 2002. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76:10929.
33. Pancio, H. A., N. Vander Heyden, K. Kosuri, P. Cresswell, and L. Ratner. 2000. Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J. Virol. 2000 74:6168.
34. Everly, D. N., Jr., P. Feng, I. S. Mian, and G. S. Read. 2002. mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. J. Virol. 76:8560.
35. He, B., M. Gross, and B. Roizman. 1997. The γ134,5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843.
36. Salio, M., M. Cella, M. Suter, and A. Lanzavecchia. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29:3245.
37. Ghiasi, H., D. C. Roopenian, S. Slanina, S. Cai, A. B. Nesburn, and S. L. Wechsler. 1997. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type I challenge. Immunology 91:430.
38. Mitchell, B. M., and J. G. Stevens. 1996. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J. Immunol. 156:246.
39. Manickan, E., and B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol. 69:8178.
40. Kämpgen, E., N. Koch, F. Koch, P. Stoger, C. Heufler, G. Schuler, and N. Romani. 1991. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc. Natl. Acad. Sci. USA 88:3014.
41. Pierre, P., I. Shachar, D. Matza, E. Gatti, R. A. Flavell, and I. Mellman. 2001. Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells. J. Exp. Med. 191:1057.
42. Mikloska, Z., and A. L. Cunningham. 1998. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J. Gen. Virol. 79:353.
43. Hsu, P. N., B. P. Wolf, N. Sutkowski, B. McLellan, H. L. Ploegh, and B. T. Huber. 2001. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis. J. Immunol. 166:3309.
44. Pereira, L. 1994. Function of glycoprotein B homologues of the family herpes-viridae. Infect. Agents Dis. 3:9.
45. Kostal, M., I. Bacik, J. Rajcani, and H. C. Kaerner. 1994. Replacement of glycoprotein B gene in the herpes simplex virus type I strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus. Acta Virol. 38:77.
46. Rajcani, J., A. Vojvodova, J. Matis, M. Kudelova, J. Dragunova, M. Krivjanska, and V. Zelnik. 1996. The syn3 strain HSZP of herpes simplex virus type 1 (HSV-1) is not pathogenic for mice and shows limited neural spread. Virus Res. 43:33.
47. Yuhasz, S. A., and J. G. Stevens. 1993. Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J. Virol. 67:5948.
48. Kosovsky, J., A. Vojvodova, I. Oravcova, M. Kudelova, J. Matis, and J. Rajcani. 2000. Herpes simplex virus 1 (HSV-1) strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence. Virus Genes 20:27.
49. Pellett, P. E., K. G. Kousoulas, L. Pereira, and B. Roizman. 1985. Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J. Virol. 53:243.
50. Lewandowski, G. A., D. Lo, and F. E. Bloom. 1993. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA 90:2005.
51. Lopez, C. 1975. Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152.
52. Chan, W. L., M. L. Tizard, and L. Faulkner. 1989. Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity. Immunology 68:96.
53. Lio, D., N. Caccamo, C. D'Anna, D. Cigna, G. Candore, and C. Caruso. 1994. Viral antibody titers are influenced by HLA-DR2 phenotype. Exp. Clin. Immunogenet. 11:182.